Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sonoma Pharmaceuticals Inc
(NQ:
SNOA
)
0.1685
-0.0103 (-5.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Sonoma Pharmaceuticals Inc
< Previous
1
2
Next >
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial Results
June 17, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
May 09, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
April 09, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
April 04, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences
March 28, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2023 Financial Results
June 22, 2023
Via
ACCESSWIRE
These Four Companies Are Attracting Investors Following Recent News
January 25, 2023
Via
AB Newswire
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
March 27, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily Use
January 23, 2024
Via
ACCESSWIRE
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
January 09, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
November 13, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
November 03, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common Stock
October 26, 2023
Via
ACCESSWIRE
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
August 15, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
August 10, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
August 03, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Introduces Next Generation Solution for Pulse Lavage Irrigation in the European Union
June 08, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Introduces Podiacyn, an All Natural, Over-the-Counter Podiatry Product for Daily Foot Care
April 11, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI North America Conference in Philadelphia
March 28, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant
March 02, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results
February 14, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea
January 31, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals (NASDAQ: SNOA) and EMC Pharma Receives DAPA Registration for Microcyn Rx Products from U.S. Department of Defense
January 25, 2023
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is a global healthcare company that is focused on the research, development and production of
Via
Spotlight Growth
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
January 25, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Launches Two New Products Expanding Its Line of Office Dispense Products Exclusively for Dermatologists and Medical Spas
January 04, 2023
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Second Quarter 2023 Financial Results
November 14, 2022
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany
October 06, 2022
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results
August 11, 2022
Via
ACCESSWIRE
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products Exclusively for Veterinarian Use and Announces Partnership with DV Medical Supply
August 02, 2022
Via
ACCESSWIRE
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
July 13, 2022
WOODSTOCK, GA / ACCESSWIRE / July 13, 2022 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous...
From
Sonoma Pharmaceuticals, Inc.
Via
AccessWire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.